RETRACTION: Combined therapy using LHRH-PE40 and anti-CD40 dendritic cells substantially eliminate tumor cells (Retraction of Vol 120, Pg 8093, 2019)

被引:0
|
作者
Zhang, Limin
Du, TianJiao
Ma, DongBin
Guo, Fang
Li, ZhenWei
Yan, Hua
机构
关键词
D O I
10.1002/jcb.30201
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:495 / 495
页数:1
相关论文
共 15 条
  • [1] RETRACTED: Combined therapy using LHRH-PE40 and anti-CD40 dendritic cells substantially eliminate tumor cells (Retracted article. See vol. 123, pg. 495, 2022)
    Zhang, Limin
    Du, TianJiao
    Ma, DongBin
    Guo, Fang
    Li, ZhenWei
    Yan, Hua
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (05) : 8093 - 8100
  • [2] RETRACTION: Mechanisms by which SGN-40, a Humanized Anti-CD40 Antibody, Induces Cytotoxicity in Human Multiple Myeloma Cells: Clinical Implications (Retraction of Vol 64, Pg 2846, 2004)
    Tai, Yu-Tzu
    Catley, Laurence P.
    Mitsiades, Constantine S.
    Burger, Renate
    Podar, Klaus
    Shringpaure, Reshma
    Hideshima, Teru
    Chauhan, Dharminder
    Hamasaki, Makoto
    Ishitsuka, Kenji
    Richardson, Paul
    Treon, Steven P.
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    CANCER RESEARCH, 2024, 84 (06) : 936 - 936
  • [3] RETRACTION: Leptin induces CD40 expression through the activation of Akt in murine dendritic cells (Retraction of Vol 56, Pg 912, 2020)
    Lam, Queenie Lai Kwan
    Zheng, Bo-Jian
    Jin, Dong-Yan
    Cao, Xuetao
    Lu, Liwei
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2020, 295 (34) : 12329 - 12329
  • [4] RETRACTION: PP2ACα deficiency impairs early cortical development through inducing DNA damage in neuroprojenitor cells (Retraction of Vol 109, Pg 40, 2019)
    Liu, Bo
    Lin, Lin
    Riazuddin, Saima
    Zubair, Ahmed
    Wang, Li
    Di, Li-Jun
    Li, Rui
    Dong, Ting-Ting
    Deng, Chu-Xia
    Tong, Wei-Min
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2020, 125
  • [5] RETRACTION: Hispidulin induces ER stress-mediated apoptosis in human hepatocellular carcinoma cells in vitro and in vivo by activating AMPK signaling pathway (Retraction of Vol 40, Pg 666, 2019)
    Han, Mei
    Gao, Hui
    Xie, Jing
    Yuan, Yin-ping
    Yuan, Quan
    Gao, Ming-quan
    Liu, Kai-li
    Chen, Xue-hong
    Han, Yan-tao
    Han, Zhi-wu
    ACTA PHARMACOLOGICA SINICA, 2022, 43 (06): : 1621 - 1621
  • [6] T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells (vol 30, pg 377, 2016)
    Marigo, Ilaria
    Zilio, Serena
    Desantis, Giacomo
    Mlecnik, Bernhard
    Agnellini, Andrielly H. R.
    Ugel, Stefano
    Sasso, Maria Stella
    Qualls, Joseph E.
    Kratochvill, Franz
    Zanovello, Paola
    Molon, Barbara
    Ries, Carola H.
    Runza, Valeria
    Noyes, Sabine
    Bilocq, Amelie M.
    Bindea, Gabriela
    Mazza, Emilia M. C.
    Bicciato, Silvio
    Galon, Jerome
    Murray, Peter J.
    Bronte, Vincenzo
    CANCER CELL, 2016, 30 (04) : 651 - 651
  • [7] Generation of fully mature dendritic cells from the CD14+ cell line XS52 using cytokines and agonistic anti-CD40 monoclonal antibody
    Yamada, N
    Katz, SI
    JOURNAL OF LEUKOCYTE BIOLOGY, 1998, : 22 - 22
  • [8] Immunostimulating Gene Therapy Using an Oncolytic Adenovirus Armed with CD40 Ligand Potently Kill Tumor Cells, Activates Dendritic Cells and Induces T Cell Responses
    Svensson, Emma
    Moreno, Rafael
    Milenova, Ioanna
    Christiansson, Lisa
    Alemany, Ramon
    Loskog, Angelica
    MOLECULAR THERAPY, 2014, 22 : S253 - S254
  • [9] Immunostimulating Gene Therapy Using an Oncolytic Adenovirus Armed with CD40 Ligand Potently Kill Tumor Cells, Activates Dendritic Cells and Induces T Cell Responses
    Svensson, E.
    Moreno, R.
    Milenova, I.
    Christiansson, L.
    Alemany, R.
    Loskog, A.
    HUMAN GENE THERAPY, 2014, 25 (12) : A3 - A4
  • [10] Synergistic anti-tumor efficacy of combined TLR3 and CD40 neoantigen vaccine requires Batf3-dependent dendritic cells
    Hoki, Toshifumi
    Yamauchi, Takayoshi
    Odunsi, Kunle
    Ito, Fumito
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):